{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:10:11Z","timestamp":1788315011626,"version":"build-2803163510"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Purpose<\/jats:title><jats:p>Candidemia is an alarming problem in critically ill patients including those admitted in intensive care units (ICUs). We aimed to describe the clinical and microbiological characteristics of bloodstream infections (BSIs) due to<jats:italic>Candida<\/jats:italic>spp. in patients admitted to ICUs of an italian tertiary referral university hospital over nine years.<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Methods<\/jats:title><jats:p>A retrospective observational study of all cases of candidemia in adult patients was carried out from January 1, 2010 to December 31, 2018 at a 980-bedded University Hospital in Ancona, Italy, counting five ICUs. The incidence, demographics, clinical and microbiologic characteristics, therapeutic approaches and outcomes of ICU-patients with candidemia were collected. Non-ICU patients with candidemia hospitalized during the same time period were considered for comparison purposes. Early (7 days from the occurrence of the episode of<jats:italic>Candida<\/jats:italic>BSI) and late (30 days) mortality rates were calculated.<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Results<\/jats:title><jats:p>During the study period, 188\/505 (36%) episodes of candidemia occurred in ICU patients. Cumulative incidence was 9.9\/1000 ICU admission and it showed to be stable over time.<jats:italic>Candida albicans<\/jats:italic>accounted for 52% of the cases, followed by<jats:italic>C<\/jats:italic>.<jats:italic>parapsilosis<\/jats:italic>(24%), and<jats:italic>C<\/jats:italic>.<jats:italic>glabrata<\/jats:italic>(14%). There was not a significant difference in species distribution between ICU and non-ICU patients. With the exception of isolates of<jats:italic>C<\/jats:italic>.<jats:italic>tropicalis<\/jats:italic>which showed to be fluconazole resistant in 25% of the cases, resistance to antifungals was not of concern in our patients. Early and late mortality rates, were 19% and 41% respectively, the latter being significantly higher than that observed in non-ICU patients. At multivariate analysis, factors associated with increased risk of death were septic shock, acute kidney failure, pulmonary embolism and lack of antifungal therapy. The type of antifungal therapy did not influence the outcome. Mortality did not increased significantly over time.<\/jats:p><\/jats:sec><jats:sec id=\"sec004\"><jats:title>Conclusion<\/jats:title><jats:p>Neither cumulative incidence nor crude mortality of candidemia in ICU patients increased over time at our institution. However, mortality rate remained high and significantly associated with specific host-related factors in the majority of cases.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0252165","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T18:01:47Z","timestamp":1622052107000},"page":"e0252165","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Candidemia in intensive care units over nine years at a large Italian university hospital: Comparison with other wards"],"prefix":"10.1371","volume":"16","author":[{"given":"Sara","family":"Mazzanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Brescini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Morroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Orsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Pocognoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abele","family":"Donati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Cerutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Munch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3915-3851","authenticated-orcid":true,"given":"Roberto","family":"Montalti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1098-902X","authenticated-orcid":true,"given":"Francesco","family":"Barchiesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,5,26]]},"reference":[{"key":"pone.0252165.ref001","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00134-014-3603-2","article-title":"Incidence, characteristics and outcome of ICU-acquired candidemia in India","volume":"41","author":"A Chakrabarti","year":"2015","journal-title":"Intensive Care Med"},{"key":"pone.0252165.ref002","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1007\/s00134-003-2002-x","article-title":"Candidemia in critically ill patients: difference of outcome between medical and surgical patients","volume":"29","author":"PE Charles","year":"2003","journal-title":"Intensive Care Med 2003"},{"key":"pone.0252165.ref003","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/CCM.0b013e318206c1ca","article-title":"Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study","volume":"39","author":"DH Kett","year":"2011","journal-title":"Crit Care Med"},{"key":"pone.0252165.ref004","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/CCM.0000000000000221","article-title":"Impact of therapeutic strategies on the prognosis of candidemia in the ICU","volume":"42","author":"M Puig-Asensio","year":"2014","journal-title":"Crit Care Med"},{"key":"pone.0252165.ref005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s15010-015-0845-z","article-title":"Epidemiology, clinical characteristics, and outcome of candidemia in a tertiary referral center in Italy from 2010 to 2014","volume":"44","author":"Candidemia Study Group","year":"2016","journal-title":"Infection"},{"issue":"suppl 1","key":"pone.0252165.ref006","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/jac\/dkx444","article-title":"Changes in the epidemiological landscape of invasive candidiasis","volume":"73","author":"F Lamoth","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"pone.0252165.ref007","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jcrc.2006.10.038","article-title":"Susceptibility patterns of Candida species recovered from Canadian intensive care units","volume":"22","author":"M Laverdiere","year":"2007","journal-title":"J Crit Care"},{"key":"pone.0252165.ref008","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1439-0507.2002.00741.x","article-title":"Epidemiology, treatment and outcome of candidemia: a five-year review at three Canadian hospitals","volume":"45","author":"GL Macphail","year":"2002","journal-title":"Mycoses"},{"key":"pone.0252165.ref009","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1128\/JCM.02117-09","article-title":"Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion","volume":"48","author":"M Pfaller","year":"2010","journal-title":"J Clin Microbiol"},{"key":"pone.0252165.ref010","doi-asserted-by":"crossref","first-page":"E343","DOI":"10.1111\/1469-0691.12212","article-title":"Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme","volume":"19","author":"MC Arendrup","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"pone.0252165.ref011","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1097\/CCM.0b013e31816fc4cd","article-title":"Risk factors for albicans and non-albicans candidemia in the intensive care unit","volume":"36","author":"JK Chow","year":"2008","journal-title":"Crit Care Med"},{"key":"pone.0252165.ref012","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1128\/JCM.01283-12","article-title":"Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011","volume":"50","author":"SR Lockhart","year":"2012","journal-title":"J Clin Microbiol"},{"key":"pone.0252165.ref013","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/QCO.0000000000000215","article-title":"Clinical perspectives on echinocandin resistance among Candida species","volume":"28","author":"RK Shields","year":"2015","journal-title":"Curr Opin Infect Dis"},{"key":"pone.0252165.ref014","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s00134-017-4743-y","article-title":"The risk and clinical outcome of candidemia depending on underlying malignancy","volume":"43","author":"O Lortholary","year":"2017","journal-title":"Intensive Care Med"},{"key":"pone.0252165.ref015","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1002\/cncr.24507","article-title":"Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001\u20132007): stable incidence but changing epidemiology of a still frequently lethal infection","volume":"115","author":"NV Sipsas","year":"2009","journal-title":"Cancer"},{"key":"pone.0252165.ref016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America","volume":"49","author":"LA Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"pone.0252165.ref017","first-page":"503","volume":"48","author":"PG Pappas","year":"2009","journal-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America Clin Infect Dis"},{"issue":"4","key":"pone.0252165.ref018","first-page":"e1","volume":"62","author":"PG Pappas","year":"2016","journal-title":"Clinical practice guidelines for the management of Candidiasis: 2016 update by the Infectious Diseases Society of America Clin Infect Dis"},{"key":"pone.0252165.ref019","unstructured":"Clinical Laboratory Standards Institute. Performance Standards for Antifungal Susceptibility Testing of Yeasts. 2nd ed Supplement M60 (2020) Wayne, PA: Clinical and Laboratory Standards Institute"},{"issue":"1","key":"pone.0252165.ref020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13054-019-2497-3","article-title":"Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project","volume":"23","author":"M Bassetti","year":"2019","journal-title":"Crit Care"},{"key":"pone.0252165.ref021","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00134-018-5363-x","article-title":"What\u2019s new on emerging resistant Candida species","volume":"45","author":"A Cortegiani","year":"2019","journal-title":"Intensive Care Med"},{"issue":"suppl_3","key":"pone.0252165.ref022","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.1093\/infdis\/jix131","article-title":"Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment","volume":"216","author":"MC Arendrup","year":"2017","journal-title":"J Infect Dis"},{"key":"pone.0252165.ref023","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials","volume":"54","author":"DR Andes","year":"2011","journal-title":"Clin Infect Dis"},{"key":"pone.0252165.ref024","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/CCM.0000000000002867","article-title":"Initial antifungal strategy reduces mortality in critically ill patients with candidemia: a propensity score\u2013adjusted analysis of a multicenter study","volume":"46","author":"J Garnacho-Montero","year":"2018","journal-title":"Crit Care Med"},{"key":"pone.0252165.ref025","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jinf.2016.12.016","article-title":"Impact of echinocandin on prognosis of proven invasive candidiasis in ICU: A post-hoc causal inference model using the AmarCAND2 study","volume":"74","author":"S Bailly","year":"2017","journal-title":"J Infect"},{"key":"pone.0252165.ref026","article-title":"Evaluation of first-line therapies for the treatment of candidemia in ICU patients: A propensity score analysis","volume":"93","author":"AL Bienvenu","journal-title":"Int J Infect Dis"},{"key":"pone.0252165.ref027","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00134-014-3408-3","article-title":"Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002\u20132010)","volume":"40","author":"O Lortholary","year":"2014","journal-title":"Intensive Care Med"},{"issue":"Suppl 7","key":"pone.0252165.ref028","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"OA Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"pone.0252165.ref029","first-page":"789","volume":"45","author":"I Martin-Loeches","year":"2019","journal-title":"ESICM\/ESCMID task force on practical management of invasive candidiasis in critically ill patients Intensive Care Med"},{"key":"pone.0252165.ref030","article-title":"The epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicentre retrospective study","volume":"25","author":"H Wang","year":"2014","journal-title":"BMC Infect Dis"},{"key":"pone.0252165.ref031","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/cid\/cis305","article-title":"Septic shock attributed to Candida infection: importance of empiric therapy and source control","volume":"54","author":"M Kollef","year":"2012","journal-title":"Clin Infect Dis"},{"key":"pone.0252165.ref032","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40560-020-00450-7","article-title":"Impact of host- and early treatment-related factors on mortality in ICU patients with candidemia: a bicentric retrospective observational study","volume":"8","author":"S Ohki","year":"2020","journal-title":"J Intens Care"},{"key":"pone.0252165.ref033","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/376906","article-title":"A prospective observational study of candidemia: epidemiology, therapy, and infuences on mortality in hospitalized adult and pediatric patients","volume":"37","author":"PG Pappas","year":"2003","journal-title":"Clin Infect Dis"},{"key":"pone.0252165.ref034","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"H Wisplinghof","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0252165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T17:35:33Z","timestamp":1672248933000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0252165"}},"subtitle":[],"editor":[{"given":"Andrea","family":"Cortegiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,5,26]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0252165","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,26]]}}}